These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16102550)

  • 1. Safety of mifepristone abortions in clinical use.
    Henderson JT; Hwang AC; Harper CC; Stewart FH
    Contraception; 2005 Sep; 72(3):175-8. PubMed ID: 16102550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Gary MM; Harrison DJ
    Ann Pharmacother; 2006 Feb; 40(2):191-7. PubMed ID: 16380436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathopharmacology of excessive hemorrhage in mifepristone abortions.
    Miech RP
    Ann Pharmacother; 2007 Dec; 41(12):2002-7. PubMed ID: 17956963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.
    Cleland K; Smith N
    Contraception; 2015 Sep; 92(3):179-81. PubMed ID: 26093188
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Hausknecht RU
    Ann Pharmacother; 2006 Apr; 40(4):785-6; author reply 786. PubMed ID: 16569806
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.
    Clark WH; Gold M; Grossman D; Winikoff B
    Contraception; 2007 Apr; 75(4):245-50. PubMed ID: 17362700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion.
    Schaff E
    Contraception; 2006 Jul; 74(1):42-4. PubMed ID: 16781259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Svedas E; Maciulaitis R; Stakisaitis D
    Ann Pharmacother; 2006 Apr; 40(4):784; author reply 784-5. PubMed ID: 16595574
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal infections associated with mifepristone-induced abortion.
    Greene MF
    N Engl J Med; 2005 Dec; 353(22):2317-8. PubMed ID: 16319378
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical abortion].
    Ottesen BS
    Ugeskr Laeger; 1999 May; 161(22):3263. PubMed ID: 10485201
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical abortion practices: a survey of National Abortion Federation members in the United States.
    Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
    Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated medical abortions and the risk of preterm birth in the subsequent pregnancy.
    Liao H; Wei Q; Duan L; Ge J; Zhou Y; Zeng W
    Arch Gynecol Obstet; 2011 Sep; 284(3):579-86. PubMed ID: 20978775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone medical abortion in Albania: results from a pilot clinical research study.
    Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B;
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.